Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic loratadine for G-CSF–induced bone pain in children undergoing chemotherapy (pilot study)
IRCT20241213064045N1Phase 3Recruiting
- Sponsor
- Urmia University of Medical Sciences
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of loratadine in ostealgia, sponsored by Urmia University of Medical Sciences. Started Feb 2025; status: recruiting.
02
Drugs
loratadine
03
Conditions
ostealgia
Beyond the preview
Go deeper on IRCT20241213064045N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241213064045N1.